Chandrayaan 5
The Indian government has officially approved the Chandrayaan-5 mission, a collaborative effort between India and Japan that aims to push the boundaries of lunar exploration. The announcement was made by ISRO Chairman V. Narayanan during a special event celebrating his appointment.
“Just three days ago, we received approval for the Chandrayaan-5 mission. We will be undertaking it in collaboration with Japan,” Narayanan revealed.
The Chandrayaan-5 mission will feature a 250 kg rover, a significant leap from the 25 kg Pragyan rover used in Chandrayaan-3, making it one of India’s most ambitious lunar projects to date.
India’s Chandrayaan program has been instrumental in advancing lunar exploration since its inception. The nation’s first Moon mission, Chandrayaan-1 (2008), was historic in its discovery of water molecules on the lunar surface. Chandrayaan-2 (2019), though facing setbacks in its landing attempt, continues to provide critical scientific data through its orbiter. Then came Chandrayaan-3 (2023), which successfully demonstrated India’s ability to achieve a soft landing on the Moon’s South Pole, a feat achieved only by India so far.
Building upon these successes, ISRO is preparing for Chandrayaan-4, scheduled for 2027, which aims to collect and return lunar samples to Earth. The Chandrayaan-5 mission, meanwhile, is expected to lay the foundation for future human Moon landings.
In addition to its lunar missions, ISRO is actively working on expanding India’s presence in space exploration. One of its most anticipated projects is the Gaganyaan Mission, which aims to send Indian astronauts into space for the first time, marking a historic milestone for the country’s human spaceflight program. Additionally, ISRO has set its sights on establishing the Bharatiya Space Station, a dedicated Indian space station that will function similarly to the International Space Station (ISS).
ALSO READ: Remembering Kalpana Chawla: Here Are The Unmissable Facts About India’s Space Icon
With this new record, the Don actor has surpassed several of India's top-earning celebrities, including…
This isn’t the first time Trump’s golf victories have been questioned. Over the years, he…
The leaders will speak for as long as they deem necessary, Kremlin spokesperson Dmitry Peskov…
Thanks to its engaging storyline, witty writing, and strong performances, Dragon has received overwhelming appreciation…
Efavirenz (EFV), brand-named drugs such as Sustiva, is an antiretroviral drug utilized mostly for HIV/AIDS…
If you're frequently seeing 11:11 or 444, numerologists say it's no coincidence these are angel…